A person’s gut bacteria could determine their risk of getting skin cancer again after being treated for the disease, a new study has found.
Studies have shown that 25 to 40 percent of melanoma patients experience a recurrence after surgery and immunotherapy, NYU Langone Health said in a Friday statement announcing the new research results.